In an effort to contribute to the global research efforts into COVID-19, a team based at Uganda Virus Research Institute (UVRI), Uganda, is participating in the ISARIC/ALERRT Clinical Characterisation Protocol (CCP) observational study. This protocol seeks to support a rapid, coordinated clinical investigation of confirmed cases of COVID-19. The team has adapted and modified the protocol to fit the nature and resources of the Ugandan setting and received ethical approval from their local review board. The study is underway, with patients already successfully enrolled at the Ugandan site.
More details are available here: https://coronavirus.tghn.org/resource-sharing/uganda/